arrow
G

GutkindJ.Silvio (J. Silvio Gutkind)

University of California San Diego
H指数:140
被引数:6.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

B cell subsets are associated with durable responses in distinct cancer types after immune checkpoint inhibition

B细胞亚群与免疫检查点抑制后不同癌症类型的持久性反应相关

2026-10-280
PRE
The COX2-PGE2-PKA axis suppresses antiviral immunity by inhibiting mtDNA-dependent STING activation

COX2-PGE<sub>2</sub>-PKA轴通过抑制线粒体DNA依赖的STING激活来抑制抗病毒免疫

2026-10-160
OAAI
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

抗体药物偶联物中的微管蛋白靶向剂和拓扑异构酶I抑制剂有效载荷与放射治疗相互作用以增强免疫治疗

2025-10-240
OAAI
Inhibition of anti-apoptotic BCL2 overcomes adaptive resistance to co-targeting of the protein kinase FAK and MEK in GNAQ-driven uveal melanoma

抑制抗凋亡BCL2克服了针对FAK和MEK蛋白激酶联合靶向在GNAQ驱动的眼葡萄膜黑色素瘤中的适应性耐药

2025-09-110
OAAI
Multistate oral carcinogenesis-A prospective cohort study and a parallel case-control study in Taiwan
2025-03-010
PRE
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
2024-05-0310
OAAI
The landscape of cancer-rewired GPCR signaling axes
2024-05-012
OAAI